GLP-1 medications in Canada have changed treatment for type 2 diabetes and obesity. Canadians now encounter names such as Ozempic, Wegovy, Mounjaro and Zepbound, plus growing interest in next-generation drugs such as retatrutide. Find a Canadian Weight Management Provider What Are GLP-1 Medications? GLP-1 receptor agonists mimic or influence incretin hormone signalling involved in appetite, … Read more
Retatrutide in Canada is drawing strong interest because of clinical trial results in obesity and metabolic disease. Retatrutide is an investigational triple receptor agonist. It should not be confused with authorized medications such as semaglutide or tirzepatide. Find a Canadian Weight Management Provider What Is Retatrutide? Retatrutide is designed to activate GIP, GLP-1 and glucagon … Read more
Tirzepatide in Canada is available in Health Canada-authorized prescription products. It is used in products such as Mounjaro and Zepbound, with indications determined by each product monograph. Find a Canadian Weight Management Provider What Is Tirzepatide? Tirzepatide is a dual GIP and GLP-1 receptor agonist. It acts on two incretin hormone pathways involved in appetite, … Read more
Semaglutide in Canada is an established prescription medication used in authorized products for type 2 diabetes and chronic weight management. Unlike many experimental peptides discussed on this site, semaglutide has extensive human clinical evidence and Health Canada-authorized products. Find a Canadian Weight Management Provider What Is Semaglutide? Semaglutide is a GLP-1 receptor agonist. It mimics … Read more
If you are researching CJC-1295 in Canada, you may be looking for information about growth hormone signalling, recovery, body composition or healthy aging. CJC-1295 is an experimental growth hormone-releasing hormone analogue. Interest is high, but its regulatory status and level of human evidence matter. Peptides Canada helps Canadians understand the research and connect with qualified … Read more
A Canadian guide to BPC-157 covering potential benefits, current research, human evidence, legal status, safety and how to find legitimate peptide care in Canada.
